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The solute carrier 4 (SLC4) family, composed of 10 integral membrane proteins 
(SLC4A1-SLC4A11), mediates transportation of bicarbonate ions and solutes across plasma 
membrane. Bicarbonate ions have been implicated as playing a central role in human corneal 
endothelial ion pump to maintain corneal transparency. Several members of SLC4 gene family 
have been linked to ocular diseases in human. Given the involvement of at least two genes 
(SLC4A11 and SLC4A4) within the SLC4 family in corneal dystrophies, we hypothesized that 
this family of proteins are important to the normal function of the corneal endothelium, and that 
there could be other members of the family equally important but as yet unrecognized to be so in 
the cornea. Therefore in this study we aimed to characterize the relative expression levels of all 
SLC4 gene family members in mouse and human corneal endothelium, using real time qRT-PCR, 
in order to identify further members from this family that can serve as candidate genes for 
analysis in corneal dystrophies. Furthermore, as important proteins in the cornea, SLC4A11 and 
SLC4A4 will be subject to study in in vitro systems (i.e. corneal endothelial cell culture system), 
we therefore wanted to explore how close to the base line levels the gene expression levels 
remain after cells have been subject to expansion and culture. Our analyses revealed that all 
SLC4 bicarbonate transporter family members were expressed in both mouse and human primary 
corneal endothelium. The SLC4A11 showed the highest expression and its expression was 
approximately 2.75 times higher (2.75±0.1 [p=0.0004]) than that of SLC4A4 in human corneal 
endothelium. Hence, based on their level of expression in human corneal endothelium, the SLC4 
family members can be categorized into three groups: SLC4A11 and SLC4A4 in ‘high 
expression’, SLC4A2, SLC4A3, SLC4A7 and SLC4A5 in ‘moderate expression’, SLC4A1, 
SLC4A8, SLC4A10 and SLC4A9 in ‘very low expression’. Interestingly, during culturing of 
vii 
 
HCECs the expression of SLC4A11 in cultured cells was significantly reduced by approximately 
40% (0.59±0.04 [p=0.0026]) in early passage and by approximately 70% (0.31±0.01 
[p=0.00007]) in late passage compared to uncultured tissue. Meanwhile, the expression of 
another important gene SLC4A4 showed a significant 3-fold increase (3.74±0.16 [p=0.0011]) in 
early passage and 4-fold increase (4.04±0.5 [p=0.0088]) in late passage. Given the known 
involvement of SLC4A4 and SLC4A11 in corneal dystrophies, we speculate that the other two 
highly expressed genes, SLC4A2 and SLC4A7 are worthy of being considered next as potential 
candidate genes for corneal endothelial diseases. Moreover, the similar expression profile 
observed for the SLC4 family members within the primary corneal endothelium of mouse and 
human suggests similar forces at play in the regulation of expression of these genes in these two 
mammalian species, as well as possible conservation of the functional role played by each 
member in solute transport in the corneal endothelium through evolution. The drastically altered 
expression levels of the main genes SLC4A11 and SLC4A4, seen in late endothelial cell culture 
passages co-incident with altered cellular morphology indicate that further study should be 
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1.1 Introduction to the eye 
The eye, one of the vital sense organs, is mainly composed of three coats and three 
structures. The outer layer is made up of the transparent cornea and the protective sclera. The 
intermediate layer consists of the choroid, the ciliary body, the iris and the innermost is the retina 
which sends neural signals to the brain through the optic nerve. Within these coats lie the 
aqueous humor, the lens and the vitreous body. The aqueous humor is a clear fluid that fills the 
anterior chamber between the cornea and the lens. The lens, which converges the light on the 
retina to create a sharp image, is suspended to the ciliary body by the suspensory ligament. The 
vitreous body fills the posterior chamber bordered by the sclera and the lens.  
 
 
Figure 1.1. Structure of the eye 
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1.1.1 The cornea 
The cornea, the anterior structure of the eye, is a colorless, transparent and completely 
avascular tissue inserted into the sclera at the limbus. The average adult cornea has 
approximately 550 µm thickness in the center, although there are racial variations, and is about 
11.75 mm in diameter horizontally and 10.6 mm vertically. It has five distinct layers: the 
epithelium, Bowman's layer, the stroma, the Descemet's membrane, and the endothelium.  
The stratified squamous nonkeratinized epithelium rests firmly on the thick homogeneous 
Bowman's layer, which is a clear acellular layer composed of thin collagen fibrils embedded in a 
matrix of glycosaminoglycans and is a modified portion of the stroma. The corneal stroma, the 
thickest component, consists of approximately 60 layers of long type I collagen fibers alternating 
with keratocytes that produce collagen and ground substance. Beneath the corneal stroma is a 
thick elastic layer known as Descemet's membrane, produced by the endothelial cells posterior to 
it and considered to be the basement membrane of the endothelial cells. It serves as a barrier to 
infections.  
The endothelium is a nonvascular monolayer of highly metabolic, mitotically inactive, 
simple cuboidal cells held together by tight junctions. It is formed by the migration and 
proliferation of neural crest derived mesenchymal cells located at the periphery of the embryonic 
cornea. The endothelium is responsible for maintaining the essential deturgescence of the corneal 
stroma by transporting water or tissue fluid from the cornea. A reduction in endothelial cell 






Figure 1.2. Illustration and H & E staining of cross section of cornea.  
 
1.1.2 Maintenance of corneal transparency  
 Corneal transparency depends on regulation of the hydration of the corneal stroma and 
the mechanism by which the cornea maintains the fluid transport and its thickness has been a 
huge area of interest to researchers for decades. The still accepted pump leak hypothesis 
(Maurice DM, 1951) stated that there is the water balance between the corneal stroma and the 
aqueous humour caused by the leak of aqueous fluid into the stroma and the pump that moves 
fluid out of the stroma. The corneal stroma has a high concentration of dissolved solutes, in the 
form of hydrophilic glycosaminoglycans, which present osmotic driving force for water 
accumulation in the cornea through ionic permeability of the endothelium. To counter-balance 
this continuous leak, the endothelium is also active in ion transport, which pumps fluid 
reabsorbed from the stroma into the aqueous humour, using numerous membrane transporters 
and channels. (Bonanno JA et. al., 2003) Hence there is no net fluid transport under normal in 




1.1.3 Bicarbonate and corneal endothelial pump 
 
The bicarbonate ion has been implicated as playing a central role in the transport of 
corneal endothelial ion pump when it was discovered that the endothelial cell fluid reabsorption 
required the bicarbonate and this process was inhibited by carbonic anhydrase inhibitors. Studies 
confirmed that the electrogenic sodium-bicarbonate cotransporter NBC1 (SLC4A4) is located at 
the basolateral membrane and is responsible for HCO3
-
 uptake into the endothelial cells. (Bok D 
et. al., 2004, Jentsch TJ et. al., 1984) 
 
1.2  Overview of bicarbonate transporters  
The Human Genome Organization has applied a systematic nomenclature to human 
genes, where membrane proteins facilitating movement of soluble substrates are classed as solute 
carriers or ‘SLC’ (Wain HM et. al., 2004), According to this nomenclature, there are two gene 
superfamilies which encode the bicarbonate transporters: SLC4 and SLC26. The main difference 
is that while most SLC4 transporters mediate the cotransport of Na
+
, SLC26 proteins 
predominantly carry out the Na
+
-independent anion transport. The expressed proteins of these 
two gene families also have different tissue distribution, phylogenetic relationships, anion 
selectivity, and regulatory properties.  Moreover, unlike SLC26 anion transporters, SLC4 
homologues have not been detected in prokaryotic genomes. The characteristic phenotypes and 
various genetic diseases result from abnormalities in either membrane targeting and/or function  
of their genetic products. (Pushkin et. al., 2006, Alper SL 2005) 
All SLC4 polypeptides have in common three structural domains: an N-terminal 
hydrophilic, cytoplasmic domain, a hydrophobic, polytopic transmembrane domain, and a C-
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terminal cytoplasmic domain. (Romero MF et. al., 2004, Cordat E, 2009) The similarities and 




(1) membrane topology: a dimer with 
10–14 transmembrane (TM) 
segments separating the hydrophilic 
N and C termini 
(2) inhibition by disulfonic stilbene 
derivatives such as DIDS 
(3) glycosylation 
(1) nature of transport activity 
(2) cotransport of a cation or an anion 
(3) electrogenicity causing a shift in 
membrane potential (Vm) 
(4)  third cellular loop 
Table 1.1. Similarities and differences among SLC4 family members  
 
 
1.2.1    SLC4 family and genetic diseases 
The SLC4 family members can be functionally divided into three  groups (Figure 1.3) 
namely: 












3. Sodium dependent chloride-bicarbonate exchangers (NDCBEs) which mediate exchange 





The table 1.2 describes SLC4 family with its gene locus, protein names, aliases, functions 
and electrogenicity while the table 1.3 summarizes its tissue distribution/subcelllar location, link 













SLC4A1 AE1 Band 3 17q21-q22 electroneutral 2 
SLC4A2 AE2  7q35-36 electroneutral Many 
SLC4A3 AE3  2q36 electroneutral Many 
SLC4A4 NBCe1 NBC, 
NBC1 
4q21 electrogenic 3 
SLC4A5 NBCe2 NBC4 2p13 electrogenic 4-6 
SLC4A7 NBCn1 NBC2, 
NBC3, 
3p22 electroneutral 4 
SLC4A8 NDCBE NBC3 12q13.13 electroneutral 1 
SLC4A9 AE4  5q31 electroneutral 2 
SLC4A10 NBCn2 NCBE 2q23-q24 electroneutral 2 
SLC4A11 NaBC1 BTR1 20p12 Electrogenic;   ? 
electroneutral 
1 
Table 1.2. SLC4 base  transporters: human gene name, protein name, gene locus, function, 
electrogenicity and splice variants. (Romero MF, 2006, Cordat E, 2009) 
Figure 1.3. Molecular entities 
subdivided by functional activity. 
Sodium bicarbonate cotransporters 
(NBCs), sodium-dependent 
chloride-bicarbonate exchangers 
(NDCBE) and anion exchangers 
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opacities (Dinour D et. al., 
2004) Mental retardation 
and bilateral glaucoma 
















Hypertension susceptibility No mouse model 
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(Bok D et. al, 2003) 
SLC4A8   
Prefrontal cortex of 
brain, testis, cardiac 
myocytes, oocytes 
 No mouse model 




 No mouse model 











to choroid plexus 
defect 





CHED2, FECD, Corneal 





alterations in cornea 
(Gröger N et. al., 
2010) 
Table 1.3. SLC4 base  transporters:  tissue distribution, link to disease, phenotype of knockout 
mouse. The diseases associated with ophthalmology are shown in bold letter. (Pushkin A et. al., 
2006, Cordat E 2009) 
 
 
Genetic analyses discovered that mutations in SLC4A4 causes proximal renal tubular 
acidosis as well as ocular anomalies such as glaucoma, cataracts and band keratopathy. 
Specifically, nonsense mutation Q29X in the unique 5'-end of SLC4A4 is related to permanent 
isolated proximal renal tubular acidosis with mental retardation and bilateral glaucoma. (Igarashi 
T et. al., 1999) Another anion exchanger AE2 (SLC4A2) mRNA expression was also detected in 
fresh bovine corneal endothelial cells but since AE2 
-/-
 mice did not develop any eye phenotype, 
the question of whether the function of AE2 is compensated by another gene was raised.  
(Dinour D et. al., 2004,  Salas JT et. al., 2008, Demirci, FY et. al., 2006, Gawenis, LR et. al., 
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2004, Horita S et. al., 2005). Another study reported that mice lacking NBC3 (SLC4A7) develop 
blindness and auditory impairment as in Usher syndrome. (Bok D et. al, 2003) 
More recently, as a major success to corneal endothelial research, a putative bicarbonate 
transporter gene (SLC4A11) was identified to be responsible for two endothelial dystrophies, 
recessive CHED (CHED2) (Vithana EN et. al., 2006) and late onset FECD (Vithana EN et. al., 
2006, 2007). Studies have shown that there is an abnormal localization demonstrated by 
missense proteins expressed by both CHED2 and FECD mutants. This makes SLC4A11 gene to 
become a more clinically significant gene since the previous finding described that Harboyan 
syndrome (HS) (corneal and auditory defects) is also caused by recessive SLC4A11 mutations. 




1.2.2 Corneal dystrophies 
 
Corneal dystrophies are a group of inherited clinical disorders manifested by 
noninflammatory, bilateral opacity of corneas which cause varying degree of reduction in visual 
acuity. Based on the anatomical layer predominantly affected, corneal dystrophies can be 
classified into three groups. They are (1) anterior corneal dystrophies which affect primarily the 
epithelium, the Bowman layer, (2) stromal corneal dystrophies which affect the stroma and (3) 
posterior or endothelial corneal dystrophies which involve the Descemet membrane and the 
endothelium. Most corneal dystrophies follow Mendelian inheritance with some phenotype 
diversity. The posterior or endothelial corneal dystrophies include Congenital Hereditary 
Endothelial Dystrophy (CHED [MIM #121700 and #217700]), Posterior Polymorphous Corneal 
Dystrophy (PPCD; MIM122000) and Fuchs Endothelial Corneal Dystrophy (FECD; 
MIM136800). This group of diseases, thought to represent defects of neural crest terminal 
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differentiation (Bahn CF et. al., 1984), share common features of disease such as corneal 
decompensation, altered morphology of endothelial cells and the secretion of an abnormal 
Descemet’s membrane (McCartney AC et al., 1998, Levy SG et. al., 1996). Several genes have 
been identified as causatives of posterior dystrophies (table 1.4) and a variety of mutations i.e. 
missense, deletion/insertion and null mutations were identified in SLC4A11 gene in the 
homozygous state in CHED2 cases and in heterozygous state in FECD patients.  
 
POSTERIOR DYSTROPHIES Mode of 
inheritance 
Gene 
Fuchs dystrophy (early onset) 
Fuchs dystrophy (late onset) 
Fuchs dystrophy (late onset) 
Fuchs dystrophy (late onset) 
Fuchs dystrophy (late onset) 
Posterior polymorphous dystrophy type 1 
Posterior polymorphous dystrophy type 2 
Posterior polymorphous dystrophy type 3 
Congenital endothelial dystrophy type 1 
Congenital endothelial dystrophy type 2 























Table 1.4. Posterior corneal dystrophies (Aldave AJ et. al., 2007, Baratz KH et.al., 2010) 
 
FECD, commonest form of endothelial dystrophy in Asian eyes, is a progressive corneal 
disorder affecting the ageing population.  its prevalence is expected to rise sharply. The 
characteristic findings are outgrowths on a thickened Descemet membrane (cornea guttae), 
corneal edema and reduced visual acuity. The initial haziness and glare of vision are followed by 
painful  corneal erosions which can sometimes lead to  blindness in the elderly population 
(Klintworth GK, 2009) Since the corneal endothelial cells do not have the ability to proliferate, 
the only effective treatment for FECD is surgical intervention with corneal transplantation, 
which is associated with high risk of complications such as high astigmatism, graft rejection, 
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ocular surface defects, suture related problems and graft failure. In addition, the ever increasing 
shortage of donor material calls for viable treatment alternatives to allograft surgery, including 
genetic manipulation of host endothelial cells.  
In contrast, recessive CHED (CHED2) is a bilateral corneal disorder affecting the 
newborns and infants. Its hallmark feature is a finding of markedly thickened corneas with 
diffuse ground-glass appearance. CHED2 is sometimes associated with progressive postlingual 
sensorineural hearing loss (Harboyan syndrome) (Desir J et. al., 2008).  Homozygous mutations 
in the SLC4A11 gene cause  the CHED2  (Vithana EN et. al., 2006, Shah SS et. al, 2008, Aldave 
AJ et. al., 2007, Sultana A et. al., 2007, Jiao X et. al., 2007) and corneal transplantation 
(penetrating keratoplasty) is the only definitive treatment for this condition to date. 
  
1.2.3. Corneal endothelial cells culture 
 As corneal transplantation is treatment of choice for many corneal dystrophies and 
keratopathies that primarily affect the corneal endothelial cell monolayer and due to the fact that 
specific corneal endothelial cell replacement is a feasible alternative to whole-cornea 
transplantation, isolation and growing of these cells have been an immense area of interest for 
researchers. Since several decades ago, primary CECs have been successfully cultured from eyes 
of many species including human, monkey, bovine, rabbit, rat, and mouse (Gospodarowicz D et. 
al., 1977, MacCallum DK et. al., 1982, Joo CK et. al., 1994, Engelmann K et. al., 1998, Pistsov 
MY et. al., 1988, Nayak SK et. al., 1986) but the majority of these cells exhibited limited 
capacity to proliferate in culture and inability for long term cultures. There was also a question 





1.3 What is bicarbonate? 
Bicarbonate is a simple carbon molecule, with alkaline and anionic properties, (Figure 
1.4) that serves crucial biochemical roles in many physiological processes. Some examples 
include the photosynthesis, the energy-producing tricarboxylic acid cycle, the acid-base balance 
and the volume regulation. (Casey JR, 2006)           
     
 Figure. 1.4 Structure of bicarbonate and ball and stick model 
<Bicarbonate. Retrieved from Wikipedia: http://en.wikipedia.org/wiki/Bicarbonate> 
 
 
 1.3.1 How bicarbonate is produced 
The living cells excrete CO2 as a primary waste product. The consumed carbohydrates, 
proteins and fats are digested into monosacharrides, amino acids and free fatty acids respectively, 
which undergo different catabolic processes  to form the common intermediate product acetyl-
CoA. This acetyl CoA subsequently enters the tricarboxylic acid cycle to produce the required 
energy ATP, with CO2 as a final byproduct (Lehninger AL, 1982). 
Most (70-75%) of the CO2 reacts spontaneously with water to form carbonic acid H2CO3, 
which is in equilibrium with the  bicarbonate ion (HCO3
-
) by the acid–base conversion properties 








. Unlike CO2, the negatively charged 
HCO3
– 
is not readily permeable to biological membranes by diffusion. Therefore its transport is 




 1.3.2 How bicarbonate is excreted  
In order to maintain the body’s function, the metabolic waste product CO2 must be 
excreted. However, it has not to be in the form of bicarbonate because the major loss of this base 
would result in metabolic acidosis which is serious and could be life-threatening. This is the 
reason why nearly all of the bicarbonate is reabsorbed by various bicarbonate transporters in the 
kidneys. Instead of secreting the bicarbonate, our bodies exhale the CO2 through the lungs. 
(Casey JR, 2006) 
 
1.3.3 Some physiological roles of bicarbonate 
Because of its chemistry and its ability to undergo pH-dependent conversions, the 
bicarbonate has various physiological roles: regulation of cellular and whole-body pH, disposal 
of waste CO2/HCO3 
−
, acid/base secretion and fluid secretion. 
 
1.3.3.1 Bicarbonate and whole-body pH regulation   
There are three main buffers in blood which control the shifts of acid and base: (1) 
proteins, (2) hemoglobin, and (3) the carbonic acid–bicarbonate system. 




-  H2CO3 
It is one of the most efficient buffer systems in the body since the amount of dissolved 
CO2 is controlled by respiration. When additional H
+
 enters the blood, HCO3
–
 declines as more 
H2CO3 is formed. Unless the extra H2CO3 were converted to CO2 and H2O and the CO2 excreted 
in the lungs, the H2CO3 concentration would rise. However, not only is all the extra H2CO3 
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removed, but also the rise in H
+
 level stimulates the respiratory center in the brain followed by 
more CO2 washout with a drop in pCO2, so that some additional H2CO3 is removed. The pH thus 
changes very little. 
 
1.3.3.2 Bicarbonate and the RBC  
The metabolism of our cells continuously produces CO2, which enters the RBC via the 
plasma. Inside the RBC, the carbonic anhydrase II converts the CO2 and water into the 
bicarbonate and the H
+
. The bicarbonate transporter (AE1 or Band 3), a major membrane protein 




 (the so-called chloride shift) while the deoxygenated 
haemoglobin buffers the H
+
, enabling the RBC to take up more CO2 . When the RBC reaches the 
lungs, the reverse process takes place and the CO2 diffuses into the alveoli for excretion.  
 
1.3.3.3 Bicarbonate and the kidney 
The systemic acid–base balance of the body is chiefly controlled and maintained in the 
kidneys by three interconnected mechanisms: the reabsorption of bicarbonate, the excretion of 
acids and the de novo generation of ammonium and bicarbonate. The reabsorption of filtered 
bicarbonate occurs in the proximal convoluted tubule (approximately 80%), the thick ascending 
limb of loop of Henle and the distal convoluted tubule (16%) and the collecting duct (4%), using 
various isoforms of bicarbonate transporters. In the proximal tubule, exit of HCO3
- 
from the cell 
across the basolateral membrane  primarily takes place via the electrogenic sodium-bicarbonate 
cotransporter (NBCe1) (Aalkjær C et. al., 2004) while in the thick ascending limb, the transport 
is mediated by the electroneutral another sodium-bicarbonate symporter (NBCn1) and anion 
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exchanger 2 (AE-2). The intercalated cells of the collecting duct contain Band 3 or anion 
exchanger proteins AE1 in their basolateral cell membranes, by which HCO3
- 
exits the cells in 
exchange for Cl
-
. (Koeppen BM, 2009) 
 
1.4 Gene characterization study using Real Time qPCR SYBR
®
 Green Technology 
 
1.4.1 Quantification of gene expression at transcription level 
There are four widely used methods for the quantification of gene transcripts. They are 
Northern blotting, RNA in situ hybridization (Parker, RM et. al., 1999), RNAse protection assays 
(Hod, Y, 1992) and reverse transcription polymerase chain reaction (RT-PCR) (Weis JH, 1992), 
with each of them having its own advantages and disadvantages. Northern blotting is the only 
method that provides information about the mRNA size, alternative spliced transcripts and the 
integrity of the sample but is time-consuming and requires relatively large amounts of RNA. The 
RNase protection method is most useful for mapping the initiation and termination sites and 
intron/exon boundaries of transcripts but is not sensitive enough to detect low abundance 
transcripts. RNA In situ hybridization allows the localization of transcripts to specific cellular 
location within a tissue (Melton, DA et. al., 1984) but its sensitivity is also insufficient. The RT-
PCR, an in vitro method that involves enzymatic amplification of target mRNA sequence, poses 
superior sensitivity over these three methods and is now the most commonly used technique for 
quantification of gene expression. 
Quantitative real-time Polymerase Chain Reaction (qRT-PCR) has opened up a new era 
for researchers to quantify the genetic products (DNA and RNA).  In the past, the conventional 
PCR measured the final amount of amplified PCR product and its quantification therefore was 
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only partial and limited (semi-quantitative) In contrast, the qRT-PCR allows researchers to 
collect the data throughout the amplification process as it occurs (i.e., in real time). The reaction 
is then characterized in the exponential phase of PCR amplification by the threshold cycle 
number (Ct) (Gibson et. al,. 1996). Thus, the initial copy number of the target determines the 




Figure 1.5. Amplication curve. Threshold is the point of detection. Cycle threshold (Ct) is the 
cycle at which sample crosses threshold. For example, the sample with Ct1 requires fewer cycles 
for fluorescence detection than the sample with Ct2. (Applied Biosystems) 
 
 
There are two types of chemistry used to detect qPCR products: TaqMan
®
 chemistry and 
SYBR
®
 Green I dye chemistry. The fluorescence-monitoring system used in our study is the 
SYBR
®
 Green I dye chemistry. It is a highly specific DNA binding dye which binds to detected 
minor groove of double stranded DNA and emits the fluorescence. During the PCR, the higher 
the number of amplified products or ‘amplicons’ generated by DNA polymerase, the more 




amount of  fluorescence  proportionate to the amount of PCR products is thus produced. Due to 
its high sensitivity, reproducibility, speed, throughput and accurate quantification of mRNA 
levels from various samples, qRT-PCR becomes an indispensable tool for researchers in gene 
expression studies.  
 
1.4.2 Relative quantification in real time qPCR 
 
Real-time qPCR data are quantified absolutely or relatively using the Ct number, which 
therefore is the primary statistical metric of interest. Absolute quantification allows researchers 
to determine the exact number of transcript copies made. In contrast, relative quantification, 
which is a comparison between the expression of a gene of interest and that of reference gene or 
the expression of same gene in two different experimental conditions, is applied in most 
biological studies. (Pfaffl MW, 2001, Nolan T et. al., 2006, Gutierrez L et. al., 2008, Andersen 
CL et. al., 2004)  
Relative quantification is a method of quantification where the expression of a target 
gene in a sample is compared with that of another sample. The latter, called a calibrator, can 
either be an external standard (serial dilution of a positive sample) or a reference sample (a 
negative or untreated sample) and the results obtained are expressed in target to reference ratios. 
An internal control gene, often referred to as housekeeping gene (e.g. β-actin, ribosomal RNA, 
GADPH) is co-amplified in order to normalize the input mRNA fraction.  
Two similar mathematical models are widely applied for relative quantification of qPCR 
data: the efficiency calibrated model (Pfaffl MW, 2001) and the ΔΔCt model (Livak KJ et. al., 
2001). The comparative Ct (cycle threshold) method is used to calculate changes in gene 
expression as relative fold difference between an experimental sample and a calibrator sample 
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using the formula 2
-ΔΔCt 
where 2 is the ‘efficiency’ of the amplification.  ΔCt is obtained by 
subtracting the Ct value of the housekeeping gene from that of the target gene. Then the ΔΔCt is 
obtained by subtracting ΔCt of treated sample from that of calibrator. The relative fold change 
between the two samples is then calculated using the formula of      2
-ΔΔCt
.   
For the ΔΔCt calculation to be valid, the efficiencies of both the target amplification and 
the reference amplification must be approximately equal. A sensitive method for assessing if two 
amplicons have the same efficiency is to evaluate the variations of ΔCt values in calibrated 
diluted templates. If primer dimers were present, Ct values of all dilutions would fall around the 
same point. Initially the Ct number is plotted against cDNA input  and then the slope of the plot 
is drawn to calculate the amplification efficiency (E), which can be either expressed as 
percentage (from 0 to 1) or as time of PCR product increase per cycle (from 1 to 2) by the 




1.4.3 Accurate normalization of expression level of a target gene using multiple stable 
reference genes 
As mentioned above, housekeeping genes are frequently used for normalization in 
analysis of qPCR data and therefore they should be expressed uniformly regardless of 
experimental conditions, sample treatment, origin of tissue/cell types, and developmental staging. 
However, studies have shown that housekeeping gene expression can vary considerably and 
there is probably no universal reference gene with a constant expression in all tissues. 
(Warrington JA et. al., 2000, Thellin O et. al., 1999, Suzuki T et. al., 2000, Bustin SA, 2000) 
Hence, using the multiple best reference genes (three in most cases) instead of conventional use 
of a single one, results in much more accurate and robust normalization and is proved to be a 
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more valid normalization method.The candidate reference gene stability can be evaluated by 
many algorithms.  One of them is the geNorm
TM
 program, which determines the most stable 
reference genes from a set of tested genes in a given cDNA sample panel.A gene expression 
normalization factor for each tissue sample is calculated based on the geometric mean 
method(Vandesompele J et. al., 2002) Stepwise exclusion of the gene allows ranking of the 
tested genes according to their expression stability.One major challenge for using multiple 
housekeeping genes for relative quantification is the requirement for high amplification 
efficiencies (95 - 105%) across all genes, regardless of amplicon length, complexity or GC 


















1.5 Aims of study 
SLC4A11 and SLC4A4 are important proteins in the cornea as indicated by their 
involvement in several corneal dystrophies. We hypothesized that this family of proteins are 
important to the normal function of the corneal endothelium, and that there could be other 
members of this SLC4 family equally important but as yet unrecognized to be so in the cornea. 
Furthermore, as important proteins in the cornea, SLC4A11 and SLC4A4 will be subject to study 
in in vitro systems (i.e. corneal endothelial cell culture system), we therefore wanted to explore 
what gene expression changes take place during cell culturing procedure and the extent to which 
the normal expression levels remain within the cultured cells. This information will be valuable 
when interpreting data generated from cultured cells. 
Therefore, in this study, the following objectives were undertaken: 
 To characterize the expression levels of the entire SLC4 family of genes relative to those of 
SLC4A4 and SLC4A11 in both human and mouse corneal endothelium, so that we may 
identify further members from this family of genes that can serve as candidate genes for 
analysis in corneal dystrophies.  
 To characterize/quantify the expressional alterations that occur for SLC4 genes due to cell 









II. MATERIALS AND METHODS 
 
2.1 Animal experimentation 
 C57BL6 WT mice were ordered from animal holding unit of National University of 
Singapore, housed and bred in Singhealth Experimental Medicine Center until the sufficient 
number for the study was attained. Approval was obtained from the SingHealth International 
Animal Care and Use Committee (IACUC No. #2008/SHS/372), and all procedures performed in 
this study were in accordance with the Association for Research in Vision and Ophthalmology 
(ARVO) resolution for the use of animals in research. The number of animals used in this study 
as well as any potential distress or discomfort to the animals was kept at minimum in accordance 
with the above mentioned resolution. 
 
2.2 Primer design 
 PCR primers were designed for all SLC4 gene family members (SLC4A1 to SLC4A11). 
The pairs of primers for the target mRNAs were designed based on the mouse and human mRNA 
sequence using Primer 3 software (Rozen S and Skaletsky H, 2000). The forward and reverse 
primers were designed in that they were located on separate exons (with a large intron in 
between) to ensure that the template utilized would be cDNA rather than genomic DNA. Each 
primer sequence was queried against the human and mouse DNA databases in the National 
Center for Biotechnology Information (NCBI) website using the Basic Local Alignment Search 
Tool (BLAST) to ensure that primer sequences were specific for the target mRNA transcript. 
The primers were synthesized by AIT Biotech (Singapore). The primers were also designed such 
that they were in a region common to all known splice variants of the corresponding transcript 
22 
 
and if they performed poorly in empirical tests then they were redesigned until the ideal primers 
were obtained. The optimized primer sequences used in the study are shown in the Table 2.1 and 
2.2. 







































































































































































































Table 2.2 Sequences of the human primers used in the study. 
2.3 Sample collection 
For mouse samples, adult 4-6 week old C57BL6 WT mice (n=5 for primary corneal 
endothelial cell culture and n=10 for direct corneal endothelial RNA extraction) were sacrificed 
with an overdose of sodium pentobarbital. Eyes were enucleated and the globes were rinsed with 
sterile PBS.. The corneas were then dissected from the globe and laid endothelial side uppermost 
in a sterile Petri dish containing PBS. 
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For human samples, a total of seven research-grade corneoscleral tissues (five used for 
direct RNA isolation and two used for cell culture) from cadaver human donors considered 
unsuitable for transplantation were obtained from Lions Eye Institute for Transplant & Research, 
Inc. (Tampa, FL, USA) and Sri Lanka Eye Donation Society (Colombo, Sri Lanka). The donors’ 
information are described in the Table 2.3. 
No. Age Sex Race Cause of death Elapsed time 















48 Male Asian Cerebrovascular 
accident 




















49 Male Caucasian Cerebrovascular 
accident 





34 Female Caucasian Metastatic cancer 8hr 31mins 5 days 
 
Table 2.3. Donors’ information of corneas. 
2.4 Mouse corneal endothelial cells culture  
Several culture media were tested to identify the optimal culture conditions for primary 
culture of mouse corneal endothelial cells (MCECs). The culture media used by Kaji et. al. for 
the primary culture of bovine corneal endothelial cells was found to be optimal for growth of 
MCECs. Therefore, primary culture of MCECs was carried out using conditions reported by Kaji 
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et. al. and cells were cultured in minimum essential media (MEM, Invitrogen, CA, USA) with 
15% fetal bovine
 
serum (FBS, Invitrogen, CA, USA) and 20 mg/L gentamicin.  
 Specifically, upon detachment, the mouse eyes were placed in Dulbecco's Modified 
Eagle's Medium (DMEM, Invitrogen, CA, USA) supplemented with 0.1mg/ml gentamicin and 
1.25g/ml amphotericin B. The Descemet’s membranes were then stripped under a dissecting 
microscope and incubated overnight to stabilize the cells in Opti-MEM I
®
 medium supplemented 
with 8% FBS, Penicillin/Streptomycin, 0.5mg/ml gentamicin and 1.25g/ml amphotericin B. 
After removing the incubating medium, cells were digested away from the Descemet’s 
membranes by a collagenase A treatment (Sigma, MO, USA) carried out at 37
o
C for 2-3 hours in 
MEM medium supplemented with 15% FBS, 20g/ml gentamicin and 2mg/ml collagenase A. 
Cells were then washed with DMEM medium supplemented with antibiotics before culturing in 
MEM medium supplemented with 15% FBS and 20g/ml gentamicin. Cells were grown in a 
humidified atmosphere of 5% CO2 at 37 °C. 
The cultures were passaged on reaching 80% confluence. The MCECs in passage 2 and 
passage 7 were used for subsequent RNA extraction. The entire experiment was repeated once 
again independently, to obtain another batch of cells at passage 2 and 7. 
 
2.5 Human corneal endothelial cells culture  
The HCECs were kindly provided by Dr. Gary Peh Swee Lim of Ocular Tissue 
Engineering and Stem Cell group from Singapore Eye Research Institute and they were cultured 
according to the protocol, developed by the group. Briefly, the donor cornea underwent a series 
of antibiotic washes (3x 15 minutes each). The isolation of HCECs involved a two-step peel-and-
digest method. Fristly, the Descement’s membrane, together with the corneal endothelium was 
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carefully peeled and stripped off from the corneal stroma under a dissecting stereomicroscope. 
The freshly peeled DM-endothelial layers were subjected to an enzymatic digestion using 
collagenase (2mg/mL) for at least 2 hours, and further dissociated using TrypLE™ Express 
(Invitrogen, CA, USA) for approximately 5 minutes. Isolated HCECs were plated onto culture 
dishes coated with FNC coating mix
® 
(Athena Environmental Sciences, MD, USA). The media 
used were Opti-MEM-I supplemented with 8% FCS, 20ng/ml NGF, 5ng/ml EGF, 20µg/ml 
ascorbic acid, 200mg/L calcium chloride, 100µg/ml pituitary extract, 50µg/ml gentamicin, 1x 
antibiotic/antimycotic, 0.08% chondroitin sulphate. The HCECs in passage 2 and passage 5 were 
used for subsequent RNA isolation.. 
 
 
2.6 RNA isolation (from corneal endothelium and cultured cells of MCECs and HCECs) 
The Descemet’s membranes with corneal endothelial cells were stripped from the 
periphery of the cornea towards the central region under a dissecting microscope. Total RNA 
was extracted by TRIZOL™ (Invitrogen, CA, USA) method following manufacturer’s protocol 
with a few modifications. The stripped Descemet’s membranes were homogenized in TRIZOL™ 
reagent using sonicator. In the case of cultured cells, the cells were directly lysed in a culture 
dish by adding TRIZOL™ reagent and the cell lysate was homogenized several times through a 
20-gauge needle. To each 1 ml of TRIZOL™ reagent, 1µl of glycogen (5µg/µl) and 0.2ml 
chloroform were added, kept at room temperature for 10 minutes and centrifuged at 10,000g for 
20 minutes at 4˚C. The aqueous layer (top, clear layer) was transferred to a fresh RNase free tube 
and mixed with 0.5ml isopropanol and incubated overnight at -20˚C. The reaction was 
centrifuged at 10,000g for 20 minutes at 4˚C, isopropanol was removed and mixed with 1ml of 
cold 75% ethanol. Ethanol was removed after centrifugation at 7500g for 4 minutes at 4˚C. The 
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RNA wash with ethanol was done twice and the resulting pellet dissolved in RNase free water. 
Genomic DNA was removed by digestion with DNase I (AmpGrade; Invitrogen-Gibco, CA, 
USA) according to manufacturer’s protocol. RNA samples were transferred to RNase-free 
eppendorf tubes and stored at -70˚C. 
 
2.7 Determination of quantity and quality of total RNA 
The concentration of RNA was determined by measuring the absorbance at 260 nm (A260) 
in a spectrophotometer (Nanodrop 2000, ThermoFischer Scientific, USA). The quality of 
extracted RNA was estimated by the A260/A280 ratios of the samples.  
 
2.8 Reverse transcription 
RNA was reverse transcribed using SuperScript™
 
III First-Strand Synthesis System for 
RT-PCR (Invitrogen, Carlsbad, CA, USA), according to the manufacturer’s protocol. Briefly, 
one microgram of total RNA with  random hexamers and  dNTP mix was heat denatured at 65˚C 
for 5 min and chilled on ice for 1 min. Reverse transcription was carried out in  RT buffer, 
25mM MgCl2, 0.1M DTT, 40 units of RNaseOUT and 200 units of Superscript™ III reverse 
transcriptase in a final volume of 20 μl. The reaction was incubated for 10 min at 25˚C, 50 min at 
50˚C, 5 min at 85˚C and then chilled on ice. After the reaction was collected by brief 
centrifugation, any remaining RNA was digested by incubation for 20 min at 37˚C with 1 µl of 






2.9 Polymerase chain reaction (PCR) amplification 
A conventional PCR amplification was performed in a 50 μl reaction volume containing 
50-100 ng of cDNA template, 0.1-0.5 μM of each primer, 2mM MgCl2, 0.2 mM dNTP, 1x Green 
GoTaq
®
 Flexi Buffer (Promega, WI, USA) and 1.25 units of GoTaq
®
 DNA Polymerase 
(Promega, WI, USA). PCR reaction was carried out after an initial denaturation for 3 min at 
95˚C followed by 40 cycles of 30sec denaturation at 95˚C, 30 sec at 58˚C, and 1 min 30 sec 
extension at 73˚C. This was followed by a final cycle for 7 min at 72˚C in a thermal cycler 
(GeneAmp
®
 PCR System 9700, Applied Biosystems USA). The amplified product was analyzed 
by agarose gel electrophoresis. 
 
2.10 Agarose gel electrophoresis  
This technique was used to determine/visualize the size of the cDNA fragments generated 
by PCR. A   2 % (w/v) agarose gel was prepared by melting 2g of powdered agarose (Promega, 
WI, USA) in 100 ml of 1 x TAE buffer  (0.04 M Tris base, 0.02 M glacial acetic acid and 0.001 
M EDTA). The agarose was melted in a microwave oven and then cooled to about 60˚C before 
addition of 10µl of 10mg/ml ethidium bromide (Sigma-Aldrich, MO, USA). The cDNA samples, 
together with size standard DNA Hyperladder IV (Bioline, UK) were loaded into the wells of the 
gel and subjected to electrophoresis in 1x TAE buffer. The gel was then viewed under UV 
illumination and the images were taken by Hamamatsu image detection system. (Japan) 
 
2.11 Immunocytochemistry 
Immunocytochemistry for HCECs was done according to the protocol provided by the 
Ocular Tissue Engineering and Stem Cell group from Singapore Eye Research Institute. 
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Specifically, cover slips were sterilized and placed into organ-culture culture dishes (BD). The 
cover slips were coated with a FnC Coating Mixture for at least 30 minutes at 37° C. HCEC cells 
were subcultured and grown in 5 % FBS supplemented medium overnight. The next day, the 
medium was discarded and the cells were washed with PBS twice. The cells were treated as per 
experimental requirements, then washed and fixed in 4 % paraformaldehyde for 30 min at 4° C. 
The cells were washed and permeabilized in a blocking solution made up of 10% normal goat 
serum containing 0.1% Triton X-100 for 30 minutes at room temperature. The cells were then 
incubated with primary antibodies diluted in 5 % serum at recommended dilutions (1:40 for 
Na+K+ ATPase (5µg/mL; Santa Cruz Biotechnology, CA, USA); 1:50 for Zonular Occludens-1 
(ZO-1 5µg/mL; BD Biosciences, NJ, USA) overnight at 4° C. The next day, the cells were 
washed twice for 10min each and incubated with a goat–anti-mouse secondary antibody (1:750, 
diluted in 5% serum), together with a rhodamine conjugated anti-phalloidin (1:500 (0.5µM); 
Invitrogen, CA, USA) at room temperature for 1h in the dark. All steps from here on were 
carried out in the dark. Subsequently, the cells were incubated with DAPI (1:50,000) a nuclear 
marker, for 5 min at room temperature, washed, and mounted onto slides using anti-fade 
mounting medium. The slides were examined using a Zeiss Axioplan 2 fluorescence microscope 
(Zeiss, Germany). 
Immunostaining of MCECs was done using the same method as described above except 





(200µg/mL; Santa Cruz Biotechnology, CA, USA) and anti-ZO-1 antibodies (5µg/mL; Life tech, 




 ATPase and 1:50 for ZO-1) and then 




2.12 Selection of most stable housekeeping gene using geNorm™ software 
The downloaded geNorm™ VBA applet for Microsoft Excel version 3.5 (Biogazelle, 
Belgium) was installed and applied according to the manufacturer’s protocol. Briefly, the 
expression data matrix with raw data of relative quantities of each housekeeping gene was 
entered into the geNorm™ software to calculate average expression level stability (M). The 
genes with the lower M values are considered to have more stable expression levels. The 
geometric mean of the most stable reference genes were calculated to obtain the normalization 
factor using the geNorm™ software. The details of the underlying principles and calculations are 
described in Vandesompele et al (2002) 
 
2.13 Real time qPCR with SYBR
®
 Green I dye for detection 
  Real time qPCR with SYBR® Green I dye for detection was performed using the 
LightCycler® 480 (Roche, Basel, Switzerland). The reaction was performed in a total volume of 
10 μl containing 1 x Power SYBR® green PCR master mix (Applied Bisosystems, USA), 80nM- 
160nM of each primer and 15ng of cDNA template. The threshold cycles (Ct) were calculated 
using the LightCycler® software v1.5 (Roche, Basel, Switzerland). Real time qPCR was carried 
out after an initial denaturation for 10 min at 95˚C followed by 45 cycles of 30sec denaturation at 
95˚C, 30sec annealing at 58˚C and 45sec extension at 72˚C. These cycling parameters were 
found to be optimal for amplifications of targets in our study. 
Real time qPCR detections of SLC4 genes and housekeeping genes in mouse primary 
corneal endothelium and cell culture samples were performed, in parallel with standard templates 
and negative controls (without the cDNA templates) as described below. In a given experiment, 
endothelia of 20 mouse corneas were pooled to obtain sufficient RNA quantities representative 
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of that from the primary endothelium. This RNA was used for two separate first strand synthesis 
reactions (reverse transcription (RT) reactions) and the resulting cDNA was used for two 
separate qRT-PCR reactions. In each qRT-PCR run the genes were analyzed in 4 replicates thus 
yielding 4 data points (i.e Ct values) for each gene. Therefore with the 2 separate qRT-PCR runs 
8 data points were obtained for each gene. Similarly, for the cultured cells the experiment was 
initiated by pooling endothelia from 10 corneas and establishing a growing culture. RNA was 
then extracted from cells at passage 2 and from cells at passage 7. As described earlier for the 
primary endothelium, the RNA from passage 2 and passage 7 were also subjected to two separate 
first strand synthesis reactions and the resulting cDNA used for two separate qRT-PCR reactions. 
Therefore for each passage, the 2 separate qRT-PCR runs resulted in 8 data points for each gene. 
The qRT-PCR data from the primary endothelium and cultured cells were paired for analysis 
purposes when comparing gene expression alterations that take place due to the cell culturing 
procedure. This paired experiment was then repeated once more independently (for both cultured 
and primary endothelium) as described to confirm the validity of data. Figure 2.1 
diagrammatically depicts the experimental procedure used for the Slc4 gene expression (via 




Figure 2.1. Schematic diagram for experimental workflow used for SLC4 family gene 
expression analysis in MCECs.   
  
For the analysis of SLC4 gene expression in primary corneal endothelial cells in humans, 
five donor tissue samples were used. The RNA sample from each donor sample was subjected to 
two RT reactions and the resulting cDNA samples were used for qPCR with each gene analyzed 
in 4 replicates. This resulted in 8 qRT-reactions/data points for a given gene in a given donor 
sample. For human cultured cell samples, the same procedure was followed as described earlier 
with the cultured mouse samples. Here the cell culture was initiated by endothelia isolated from a 
single human donor cornea. As with the cultured MCECs, two separate cDNA samples were also 
prepared from a given RNA sample derived from cells of a given passage (see Figure 2.2 for 
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more details). Again this resulted in 8 qRT-reactions/data points per given gene for a given 
passage. The experimental procedure for the cultured cells was repeated once more to test the 
reproducibility of .data.   
 
 
Figure 2.2. Schematic diagram for experimental workflow used for SLC4 gene expression 
analysis in HCECs.   
 
We carried out the following comparisons: 
1. The expression of SLC4 genes, in both murine and human primary corneal endothelium, was 
compared against the expression levels of SLC4A11 and SLC4A4 genes. Relative quantification 
of gene expression was carried out using the comparative CT method (i.e the 2
-ΔΔCt 
method (Livak 
and Schmittgen, 2001). The expression levels of SLC4 bicarbonate transporters in each primary 
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uncultured sample were normalized against the expression levels of the most stable 
housekeeping gene, i.e., Hprt1 for mice and GAPDH for the human samples. This was 
determined by using the geNorm™ software as explained in section 2.12. In this analysis, results 
were reported as a relative gene expression level of a given gene over a control gene, i.e, 
SLC4A11 or SLC4A4.  
2. The expressional changes that occur in SLC4 genes due to the culturing procedure 
were also analyzed by comparing against the gene expression in uncultured/primary cells. In this 
analysis the samples from the primary endothelium were treated as the control or the calibrator 
sample while samples from cultured cells served as the experimental samples. Results were 
reported as relative fold change of experimental sample over control sample. A fold change of >1 
meant that experimental samples had increase in expression over the calibrator samples while a 
fold change of <1 meant a decrease in expression. Here we used a normalizing factor taking into 
account the expression of several housekeeping genes rather than a single normalizing gene. 
 
2.14 Statistical analysis 
When performing expressional analysis of Slc4 family genes in MCECs, all the data used 
for statistical analysis were obtained from two independent experiments. In the case of HCECs, 
when carrying out the analysis of relative mRNA expression levels of SLC4 genes in human 
corneal endothelium, we use the data obtained from five donor corneal samples for testing 
statistical significance. However, when determining the expressional alterations that occur in 
cultured HCECs, the data used were obtained from two independent experiments. The 
significance of difference between the groups was determined by the two-tailed Student’s t-test 





3.1 Investigation of expression of Slc4 transporter family in MCECs 
 
In order to compare the mRNA expression levels of Slc4 gene family members in mouse 
primary corneal endothelium and to investigate the changes that occur in their expression during 
cell culture, the primary MCECs were cultured and total RNAs were extracted from primary 
endothelium and cultured cells (at passage 2 and passage 7). For semi-quantitative analysis of 
gene expression, reverse transcription-polymerase chain reaction (RT-PCR) was performed and 
analysed by electrophoresis. For relative quantification of gene expression, real time qPCR with 
SYBR
®
 green detection was carried out. The current gold standard method for relative 
quantification was employed, using a combination of several housekeeping genes rather than a 
single gene. The housekeeping gene which expressed most stably under a given experimental 
condition (i.e, cell culture in this study) was carefully chosen by geNorm™ software and the 
normalization factor was used for more accurate normalization.   
 
3.1.1 Culture of mouse corneal endothelial cells (MCECs) 
 
Primary MCECs were isolated from corneas of wild type C57BL6 mice. The Descemet’s 
membrane-endothelial layers of 8-10 week old, in-bred mice (n=15) were gently stripped from 
corneas using a dissecting microscope (Figure 3.1A, 1B) and divided into two groups for both 
primary cell culture (n=5) and direct RNA extraction (n=10). CECs were grown under optimized 
culture conditions, as described in section 2.4. Initially, the cultured cells showed stellate 
morphology at low densities, and upon confluence, they became polygonal in shape, 
characteristic of endothelial cells (Figure 3.1C, 1D). Cultures were split (i.e. passaged) upon 
reaching 80% confluence and passaging was carried out until the seventh passage for this study. 
36 
 
In the latter passages, some cells were more elongated in appearance while some appear larger in 




Figure 3.1. Isolation and establishment of mouse corneal endothelial cells (MCECs).  A. and 
B. Phase contrast micrographs of descemet’s membranesstripped from the corneas of wild type 






3.1.2 RNA extraction and RNA quality 
Total RNA was extracted from primary corneal endothelium as well as from cultured 
MCECs at passage 2 and 7 (upon confluence) as described in section 2.6. To obtain sufficient 
amount of RNA for experimentation, a total of 20 mouse corneal endothelia had to be pooled for 
RNA isolation (See figure 2.1 for experimental workflow). The concentration of RNA was 
determined by UV spectrophotometry. The ratio of the readings at 260 nm and 280 nm 
(A260/A280) provides an estimate of the purity of RNA with respect to contaminants that absorb 
in the UV, such as protein. Good quality RNA is expected to have an A260/A280 ratio of 1.9–2.1 
in slightly alkaline pH (Sambrook J et. al., 1989). The absorbance readings for all RNA samples 
extracted from primary corneal endothelium, cultured MCECs at passage 2 and passage 7 were 
within this range, indicating RNA preparations with sufficient quality suitable for subsequent 
analyses. 
 
3.1.3 Determining amplification efficiency and quality of the primers 
When using ΔΔCt model for relative quantification, the formula 2
-ΔΔCt 
 is applied where 2 
is the ‘efficiency’ of the amplification. In order for this equation to be valid, the amplification 
efficiencies of both the gene of interest and the housekeeping gene (HKG) must be optimally 
equal to 2 (100% efficiency). Thus we initially validated the efficiencies of all the primers of 
Slc4 family genes and HKGs by real time qPCR with SYBR
®
 green detection, using mouse 
kidney cDNA as standard template. Mouse kidney cDNA was used for this purpose since all Slc4 
genes were shown to be expressed in mouse kidney tissue (Nishimura M et. al., 2005) and 
sufficient quantities of RNA could be extracted from kidney tissue. Amplification analyses using 
six serial dilutions of template showed high amplification efficiencies for all the primer pairs 
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employed to amplify the HKGs as well as the Slc4 genes. The efficiency is described as time of 
PCR product increase per cycle by the formula E = 10
–1/slope
.  Consistent, high amplification 
efficiencies (95 - 105%) were achieved in all cases, indicating the validity of using ΔΔCt method 
(See figure 3.2 and table 3.1) 
Furthermore, melting curve analysis was performed for all the primer pairs to ensure that 
a single specific melting peak was observed without a ‘secondary peak’, which indicates the 
presence of primer dimers. As SYBR
®
 green dye can detect all double-stranded DNA, it is 








Figure 3.2. PCR amplification efficiency plots. The reaction efficiency achieved for each gene 
was calculated using the Ct slope method, with six data points corresponding to log10-fold 
























Slope -3.55 -3.51 -3.32 -3.58 -3.17 -3.52 -3.48 -3.56 -3.17 -3.13 
Efficiency 
(E) 




β-actin Hprt1 Gapdh 
18S 
rRNA 
Slope -3.30 -3.15 -3.08 -3.23 
Efficiency (E) 2.00 2.08 2.11 2.04 
Table 3.1. The amplification efficiencies for mouse Slc4 family genes and housekeeping 
genes used in the study. The efficiency is described as time of PCR product increase per cycle 
by the formula E = 10
–1/slope
.  Consistent, high amplification efficiencies (95 - 105%) were 







3.1.4  Semi-quantitative analysis of Slc4 family gene expression by reverse transcription 
polymerase chain reaction (RT-PCR) 
 
First strand cDNA was synthesized from total RNA of mouse primary corneal 
endothelium as well as cultured cells (in passage 2 and passage 7) as described in methods 
section 2.8. Equal amount of cDNA template was used for standard PCR with Taq DNA 
polymerase using primers that were selected specifically to target the mRNA of the said genes. 
The resulting PCR products were separated by gel electrophoresis and visualized by ethidium 
bromide staining. The four housekeeping genes (Gapdh, actb, hprt1, 18S rRNA) were used as 
amplification (positive) and normalizing controls.  
A single RT–PCR product of the predicted size for a given mRNA template was observed 
for each primer pair indicating there was no contamination by genomic DNA and confirmed the 
amplification of mRNA. This analysis found that all Slc4 genes were expressed in corneal 
endothelium and cultured MCECs.  It also indicated Slc4a11 and Slc4a2 genes as having the 
highest expression levels whilst Slc4a1 and Slc4a9 appeared to have the lowest expression levels 
in both primary corneal endothelium and cultured cells. However, it should be noted that this 
analysis is semi-quantitative and not as sensitive (or always accurate) as real time qPCR for 
assessment of relative gene expression. RT-PCR is more an accepted methodology for assessing 





Figure 3.3.  RT-PCR results from the cDNA samples generated from  (1) mouse primary 
corneal endothelium (2) cultured passage 2 MCECs (3) cultured passage 7 MCECs.   100bp 
size marker is shown in the first lane from the left.  The primers used to generate the PCR 
products (Table 2.1) are indicated below each lane. The four HKGs (Gapdh, Actb, Hprt1 and 18S 
rRNA) were used as amplification (positive) controls. Each set of reactions (per gene) included a 
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no-template negative control, these samples were pooled and the combined sample (NT) was 
subjected to electrophoresis.   
   
 
3.1.5 Assessment of corneal endothelial markers in cultured MCECs 
In order to characterize MCECs, the expressions of several genes normally present in 
endothelial cells (Aqp1, Zo-1, Col8a2) as well as fibroblastic marker Col1a1 was examined by 
reverse transcription PCR. It was observed that MCECs from both early and late passages 
expressed endothelial markers Aqp1, Zo-1 and Col8a2. However, the fibroblast cell marker 
Col1a1 was not expressed in early passage 2 cells but was expressed in late passage 7 cells. (See 
figure 3.4D)  
We further characterized the cells with  immunofluorescent analyses on the cultured 




ATPase and ZO-1. This analysis was limited to 





ATPase is required for proper physiological control of corneal thickness by the 
corneal endothelium [Riley MV (1977), Gerosk DH (1985)]; whilst tight junction-associated 
protein ZO-1 is involved in the formation of focal tight-junction complexes [Joyce NC (2003), 




ATPase and ZO-1, which are 









ATPase and (B) 
ZO-1 in MCECs. Cells in passage 2 were immunostained with the indicated antibodies and 
visualized by fluorescent microscopy. (C) Isotype matched IgG1 negative control. Scale bar: 
50µm. (D) mRNA expression of Aqp1, Zo-1, Col8a2, Col1a1 in (i) passage 2 MCECs and (ii) 
passage 7 MCECs. Cultured MCECs were harvested and analyzed by reverse transcription PCR. 
Size markers are shown in the first lane from the left. Note that the fibroblast marker Col1a1 was 












3.1.6 Selection of most stable housekeeping gene (HKG) using GeNorm
TM
 analysis 
When comparing gene expression across different tissues or conditions, for example 
primary endothelium versus cultured cells, selection of most stable HKGs from an array of 
HKGs and use of multiple housekeeping genes have become a norm for more robust and 
accurate normalization and quantification (see method section 2.12 for more details). In this 
study, the most stable reference genes were selected from four most commonly used HKGs 
(Gapdh, Actb, 18S rRNA and Hprt1) using the geNorm
TM
 software (Biogazelle, Belgium). They 
were systematically compared with each other and the resulting average expression stability plot 
was used to rank each HKG in order of expression stability. (See figure 3.5A) According to this 
analysis, Hprt1 was found to be the most stable gene whilst Gapdh was the least stable gene and 
therefore unsuitable for normalization. Subsequently, the normalization factor was calculated 





Figure 3.5. GeNorm™ analysis. (A) The relative quantities of four HKGs were entered into the 
geNorm™ software to calculate average expression level stability (M). The genes with the lower M 
values are considered to have more stable expression levels. (B) The geometric mean of the most 







3.1.7 Relative mRNA expression levels of Slc4 transporter genes in mouse corneal 
endothelium 
In order to evaluate the relative expression levels of Slc4 gene family within the murine 
corneal endothelium, the expression of each Slc4 gene was normalized using the most stable 
housekeeping gene Hprt1 (obtained by the calculation as described in section 3.1.5), and then 
compared against the most clinically important genes Slc4a11 and Slc4a4. Therefore data is 
described as the expression levels of Slc4 genes relative to that of Slc4a11 or Slc4a4. The 
relative mRNA expression levels of all Slc4 genes in mouse corneal endothelium are shown in 
table 3.2. The ΔCt and ΔΔCt values for a given gene were derived from a single experiment (i.e. 
8 qRT-PCR data points/gene) as explained in details in methods section 2.11. However for the 
calculation of p-values, fold data from the two independent experiments was used (see legend of 
table 3.2), and in this experimental context indicate the reproducibility of relative expression data.  
The same analyses were carried out for cultured passage 2 and passage 7 MCECs (see 
appendix A and B).  However results for the cultured cells are not elaborated here as the aim of 








Table 3.2. Relative normalized mRNA expression levels of Slc4 gene family in mouse 
corneal endothelium. Data are described as the expression levels of a given gene relative to that 
of Slc4a11 (in column 4) and Slc4a4 (in column 7).  
 
a. The ΔCt value was determined by subtracting the average Hprt1 Ct value from the average Ct value of gene of 
interest (Goi). The standard deviation (SD) of the difference was calculated from the standard deviations of the Ct 
values of Goi and Hprt1 by the formula . The mean and SD values were obtained from a data 
pool of 8 reactions.  
b. The calculation of ΔΔCt involved subtraction by the ΔCt calibrator (Slc4a11 or Slc4a4) value. This is subtraction 
of an arbitrary constant, so the SD of ΔΔCt is the same as the SD of the ΔCt value. 
c. The range given for nomalised expression relative to Slc4a11 or Slc4a4 was determined by evaluating the 
expression: 2
-ΔΔCt with ΔΔCt + s and ΔΔCt – s, where s = SD of the ΔΔCt value.  
d. P values indicate the significance between the normalized expression of given gene and normalized expression of 
the calibrator gene (Slc4a11 or Slc4a4) from two independent experiments. *P < 0.05 
 
According to this analysis, Slc4a11 showed the highest expression level whilst Slc4a1 
showed the lowest. This result was supported by the previous semi-quantitative analysis (see 
section 3.1.3). The exact order of expression level was therefore Slc4a11 being highest followed 
by Slc4a2, Slc4a4, Slc4a7, Slc4a3, Slc4a10, Slc4a5, Slc4a9, Slc4a8 and Slc4a1. The expression 
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of Slc4a2 was approximately half that of Slc4a11 (0.55±0.03 [p=0.007])  while the expression of 
Slc4a1 was three hundred times less than Slc4a11(0.0026±0.0006 [p=0.003]). When comparing 
the expression levels of the two clinically important genes (i.e. Slc4a11 and Slc4a4), the 
expression of Slc4a11 was found to be approximately three times greater than that of Slc4a4 
(3.4±0.3 [p=0.004]). As the p-values indicate, the above described differences in expression 
levels between the said genes were statistically significant. 
 
3.1.8 Alteration in mRNA expression of Slc4 genes during MCEC cell culture 
 Next, we investigated the alterations in gene expression that occur in MCECs during cell 
culture. This was carried out using multiple housekeeping genes for normalization (figure 3.5A 
and B). The normalization factor was calculated using expression level data of the three most 
stable reference genes (Hprt1, Actb, 18S rRNA) across the three samples (primary corneal 
endothelium, passage 2 cells, passage 7 cells). According to this analysis, the expressions of all 
the Slc4 transporters except Slc4a4 and Slc4a10 were down-regulated in early passage 2. 
However, in late passage 7, the Slc4a1, Slc4a2, Slc4a3, Slc4a4, Slc4a7 became up-regulated 
while the remaining members were still down-regulated. The expression of Slc4a11 was 
significantly down regulated 20 fold (0.05±0.001 [p=0.000001]) in passage 2 and by 7 fold 
(0.14±0.002 [p=0.000002]) in passage 7. Interestingly, the expression of another clinically 
important gene Slc4a4 was significantly up-regulated by approximately 2.5 fold (2.52±0.07 




Fig. 3.6. Alterations in mRNA expressions of SLC4A family genes in cultured (passage 2 
and 7) mouse corneal endothelial cells compared to the primary endothelium. A. Data are 
described as the relative fold change in expression of cultured cells over primary corneal 
endothelium. Values shown are the mean±SD of two independent culturing experiments. The P 
values in last column indicate the significance between p2 and p7 change values from two 
independent experiments. *P < 0.05. B. Data are shown in graph. 
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3.2 Investigation of mRNA expression of SLC4 transporter family in human corneal 
endothelial cells (HCECs) 
 Applying the same methodology used for the gene expression analysis in MCECs, the 
expression levels of SLC4 gene family members in human corneal endothelium were also 
compared and the change in their expressions during cell culture was investigated. The whole 
corneas were ordered from Lions Eye Institute for Transplant & Research, Inc. (Tampa, FL) and 
Sri Lanka Eye Donation Society (Colombo, Sri Lanka) while the cultured HCECs were kindly 
provided by Dr. Gary Peh Swee Lim of Ocular Tissue Engineering and Stem Cell group from 
Singapore Eye Research Institute. 
 
3.2.1 Cultivation of human corneal endothelial cells (HCECs)   
 The HCECs were cultivated according to the protocol developed by Dr Gary Peh’s group. 
Briefly, the isolation of HCECs involved a two-step peel-and-digest method and then the isolated 
HCECs were plated onto culture dishes coated with FNC coating mix
®
. The protocol is 
elaborated in section 2.5. Phase contrast micrographs of HCECs showed that in early passage 2, 
the cells were polygonal in shape (Figure 3.7A and B) but in late passage 5, their morphology 
became more elongated (Figure 3.7C and D). It was reported that in some late subcultures, 





Figure 3.7. Morphology of cultured human corneal endothelial cells (HCECs).  (A) and (B) 
show HCECs observed in early passage 2 of culture  while (C) and (D) show those in late 
passage 5 .  
 
3.2.2. Immunostaining with endothelial cell markers for cell identification 










-ATPase (Figure 3.8A), an integral membrane protein complex 
responsible for regulating pump functions, reavealed that it was located at the basolateral 
memebrane while ZO-1, junctional molecule,  (Figure 3.8B) was located at the cell boundaries of 













shown in green, nucleus in DAPI blue and cytoskeletal network in Phalloidin red. (B)  ZO-1 in 
red and nucleus in DAPI blue (C) Isotype matched IgG1 negative control. (Courtesy of Dr Gary 
Peh, Singapore Eye Research Institute) 
 
3.2.3 RNA isolation and RNA quality 
Total RNA was extracted from primary corneal endothelia of five donor cornea samples 
(n=5; donors’ information can be found in table 2.3) as well as from cultured cells in passage 2 
and 5 (upon confluence) using TRIzol™ reagent as described in section 2.6. The concentration 
of RNA was determined by UV spectrophotometry (See section 2.7). Absorbance ratios (A260/280) 
for all RNA samples (primary endothelium, cultured passage 2 and passage 5 cells) were within 





3.2.4 Determining amplification efficiency and quality of the primers 
The efficiencies of amplifying all the primers of SLC4 family as well as the housekeeping 
genes were initially validated as described in the section 3.1.4, using the immortalized human 
corneal endothelial cell line (IHCEn) cDNA as template. Amplification of serial dilution of 
template showed high amplification efficiency (95% - 105%) by all primers. (See figure 3.9 and 
table 3.3)  
Again, a single specific melting peak observed on melting curve analysis for each primer 











Figure 3.9. PCR efficiency plots.  The efficiency for each gene was calculated using the Ct 
slope method, with six data points corresponding to log10-fold cDNA serial dilutions (10 ng - 50 
























Slope -3.24 -3.43 -3.22 -3.52 -3.20 -3.48 -3.26 -3.25 -3.36 -3.26 
Efficiency 2.04 1.96 2.04 1.92 2.05 1.94 2.03 2.03 1.98 2.03 
 
Housekeeping 
genes ACTB GAPDH B2M 
18S 
rRNA 
Slope -3.46 -3.35 -3.50 -3.27 
Efficiency 1.95 1.99 1.93 2.02 
 
Table 3.3. The amplification efficiencies for human SLC4 family genes and housekeeping 






3.2.5 Semi-quantitative analysis by reverse transcription polymerase chain reaction (RT-
PCR) 
 First strand cDNA was synthesized from total RNA of human primary corneal 
endothelium as well as from cultured HCECs (in passage 2 and passage 5) as described in the 
methods section 2.8. Equal amount of cDNA template was used for standard PCR with Taq 
DNA polymerase and the resulting PCR products were separated by gel electrophoresis and 
visualized by ethidium bromide staining. The four housekeeping genes (ACTB, GAPDH, B2M, 
18S rRNA) were used as amplification and normalizing controls. A single RT–PCR product of 
expected size for a given mRNA template was observed for each SLC4 gene and housekeeping 
gene, ruling out the possibility of primer dimer inclusions (See figure 3.10). 
 
3.2.6 Selection of most stable housekeeping gene (HKG) using GeNorm
TM
 analysis 
 Selection of most stable housekeeping gene was carried out as described in the section 
3.1.5, using the four widely used housekeeping genes (ACTB, GAPDH, B2M, 18S rRNA). The 
ubiquitously used GAPDH was found to be the most stable HKG while B2M was not suitable to 
be used for normalization (See figure 3.11A) Then the normalization factor was calculated using 





Figure 3.10. RT-PCR results from the cDNA samples generated from  (1) human primary 
corneal endothelium (2) cultured passage 2 HCECs, (3) cultured passage 5 HCECs. 100bp 
size marker is shown in the first lane from the left.  The primers used to generate the PCR 
products (Table 2.2) are indicated below each lane. The four HKGs (ACTB, GAPDH, B2M, 18S 
rRNA) were used as amplification (positive) controls. Each set of reactions (per gene) included a 
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no-template negative control, these samples were pooled and the combined sample (NT) was 





Figure 3.11 GeNorm™ analysis. (A) The analysis gave average expression level stability (M). 
The genes with the lower M values were considered to have more stable expression levels. (B) 







3.2.7 Relative mRNA expression levels of SLC4 genes in the human corneal endothelium 
In order to evaluate the relative mRNA expression levels of SLC4 gene family within the 
human corneal endothelium, the expression of each SLC4 gene was normalized using GAPDH 
(obtained by the calculation as described in section 3.2.6), and then compared against SLC4A11 
and SLC4A4.  The five donor corneas were used in this study. (See table 2.3 of methods section 
for donors’ information) To demonstrate that all the 5 donor corneas had comparable relative 
expression levels and the validity of the experiment, we depicted the data in terms of ΔCt values 
after normalization against the most stable internal reference gene GAPDH (Figure. 3.12). 
Although the five donor cornea samples had discrepancy in age, race, cause of death and elapsed 
time from death to corneal preservation, the expression levels of SLC4 family members in five 
corneal samples followed the same pattern of relative abundance, i.e., SLC4A11 having the 
highest expression followed by SLC4A4, SLC4A2, SLC4A3, SLC4A7, SLC4A5, SLC4A8, 
SLC4A1, SLC4A10 and SLC4A9. 
 
 
Figure 3.12. ΔCt values obtained from qRT-PCR analysis on SLC4 family gene expression 
in five human donor cornea samples. The ΔCt value was determined by subtracting the 
average GAPDH Ct value from the average Ct value of gene of interest (GOI). The mean and SD 
values were obtained from a data pool of 8 reactions. Note that the expression levels of SLC4 
family members in five corneal samples followed the same pattern of relative abundance. The 
lower the ΔCt value, the higher the expression level. 
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The relative mRNA expression levels of all SLC4 genes in the human corneal 
endothelium are shown in table 3.4.  Here the ΔCt and ΔΔCt values for a given gene were 
derived using qRT-PCR data from a single sample (i.e. 8 qRT-PCR data points/gene), 
representative of five samples, as explained in detail in methods section 2.11. However for the 
calculation of p-values, fold data from 5 independent samples (i.e. 5 corneas) were used (see 
legend of table 3.4), and in this experimental context indicate the reproducibility of relative 
expression data.   
According to this analysis, SLC4A11 showed the highest expression and its expression 
was approximately 2.75 times higher (2.75±0.1 [p=0.0004]) than that of SLC4A4.  The order of 
abundance for expression of SLC4 gene family in the human corneal endothelium was as follows: 
SLC4A11, SLC4A4, SLC4A2, SLC4A3, SLC4A7, SLC4A5, SLC4A8, SLC4A1, SLC4A10 and 
SLC4A9. Hence, based on their level of expression in human corneal endothelium, the SLC4 
family members can be categorized into three groups: SLC4A11 and SLC4A4 in ‘high 
expression’, SLC4A2, SLC4A3, SLC4A7 and SLC4A5 in ‘moderate expression’, SLC4A1, 
SLC4A8,  SLC4A10 and SLC4A9 in ‘very low expression’. The expression level of SLC4A9 gene 
was found to be negligible (0.00008±0.00001 [p=0.0004]) relative to that of SLC4A11.  
Once again, for the sake of completion we also analyzed the relative expression levels of 
SLC4 genes in cultured HCECs (see appendix C and D). These results are however not 
elaborated upon as the purpose of this analysis was to identify the abundance of SLC4 gene 
members in primary uncultured corneal endothelial cells in comparison to the clinically relevant 





Table 3.4. Relative normalized mRNA expression of SLC4 gene family in human primary 
corneal endothelium. The expression levels are described in relative to that of SLC4A11 (in 
column 4) and SLC4A4 (in column 7).  
 
a. The ΔCt value was determined by subtracting the average GAPDH Ct value from the average Ct value of 
gene of interest (GOI). The standard deviation (SD) of the difference was calculated from the standard 
deviations of the Ct values of GOI and GAPDH by the formula . The mean and SD 
values were obtained from a data pool of 8 reactions.  
b. The calculation of ΔΔCt involved subtraction by the ΔCt calibrator (Slc4a11 or Slc4a4) value. This is 
subtraction of an arbitrary constant, so the SD of ΔΔCt is the same as the SD of the ΔCt value. 
c. The range given for nomalised expression relative to SLC4A11 or SLC4A4 was determined by evaluating 
the expression: 2
-ΔΔCt with ΔΔCt + s and ΔΔCt – s, where s = SD of the ΔΔCt value.  
d. P values indicate the significance between the normalized expression of given gene and normalized 








3.2.8 Alteration in mRNA expression of SLC4 genes during HCEC culture 
As done earlier with MCECs, we also investigated the alterations in gene expression that 
occur in HCECs during cell culture. This was also carried out using multiple housekeeping genes 
for normalization (figure 3.12A, B). The normalization factor was obtained from the expression 
of three most stable reference genes (GAPDH, ACTB, 18S rRNA) across three samples (primary 
endothelium, passage 2 cells, passage 5 cells). 
 According to this analysis, in the cultured cells (passage 2 as well as 5), the expressions 
of the SLC4A2, SLC4A4, SLC4A7, SLC4A8 and SLC4A9 were significantly up-regulated while 
those of SLC4A1, SLC4A3, SLC4A5, SLC4A10 and SLC4A11 were significantly down-regulated. 
The expression of most important gene in primary corneal endothelium SLC4A11 was 
significantly reduced by approximately 40% (0.59±0.04 [p=0.0026]) in early passage and by 
approximately 70% (0.31±0.01 [p=0.00007]) in late passage. Meanwhile, the expression of 
another important gene SLC4A4 showed a significant 3-fold increase (3.74±0.16 [p=0.0011]) in 




Figure 3.13. Fold change in mRNA expressions of SLC4 family genes in cultured human 
corneal endothelial cells (in passage 2 and 5). A. Data are described as the relative fold change 
in expression of cultured cells over primary corneal endothelium. Values shown are the 
mean±SD of two independent experiments. The P values in last column indicate the significance 
between p2 and p5 change values from two independent experiments. *P < 0.05. B. Data are 





4.1 Discussion of results 
4.1.1 Characterization of mRNA expression levels of SLC4 family in corneal endothelium 
The SLC4A family is comprised of integral membrane proteins that mediate 
chloride/bicarbonate exchange or sodium-coupled bicarbonate co-transport across plasma 
membrane. SLC4A11 is the most divergent member of the family and was described as an 
electrogenic Na
+





when borate is absent (Park M et al, 2004). Our investigation discovered that all members of the 
SLC4 bicarbonate transporter family are expressed in both MCECs and HCECs but some more 
than others can serve as potential candidate genes for corneal endothelial diseases. Previous 
studies have investigated their expression in other tissues (Gottsch JD et. al., 2003, Damkier HH 
et. al., 2007), but not in ocular tissues. Amongst the family, the SLC4A11 showed the highest 
expression in both mouse and human corneal endothelium, therefore it is highly possible that it 
plays the most pivotal role in transporting solutes in the corneal endothelium although we did not 
establish functional correlation with its expression. The function of SLC4A11 in the corneal 
endothelium is unknown so far. Nevertheless, corneal endothelial function is highly dependent 
on the presence of bicarbonate, bicarbonate transport, and intracellular pH regulation (Bonanno 




 cotransport activity by 
SLC4A11 is important. 
It has been well known that homozygous mutations in the SLC4A11 cause two early-
onset corneal dystrophies: congenital hereditary endothelial dystrophy (CHED) (Vithana EN et. 
al., 2006, Aldahmesh MA et. al., 2009, Shah SS et. al., 2008, Jiao X et. al., 2007) and Harboyan 
syndrome (Desir J et. al., 2007, 2008) whereas heterozygous mutations in SLC4A11 are 
66 
 
responsible for familial cases of late-onset FCD. (Vithana EN et. al., 2007, 2008, Riazuddin SA 
et. al.,2010). Recent study on Slc4a11 mutant mice revealed severe morphological alterations in 
endothelial cell layer, such as thickening and malfunctions in ion homeostasis such as a dramatic 
increase in sodium and chloride concentrations in the corneal stroma. (Gröger N et. al., 2010)  
Our study found that the SLC4A4, SLC4A2 and SLC4A7 genes were expressed 
significantly higher than other members of the family in the corneal endothelium and hence they 
can become the important foci of future genetic studies for corneal endothelial diseases. 
Interestingly, previous studies have identified homozygous mutations in the kNBC1 gene 
(SLC4A4) in patients with permanent isolated proximal renal tubular acidosis and bilateral 
glaucoma. (Igarashi T et. al., 2003, Dinour D et. al., 2004, Inatomi J et. al., 2004, Demirci FY et. 
al., 2006). The importance of SLC4A7 in vision was also highlighted by the finding that the 
Slc4a7
–/– 
mice develop blindness and auditory impairment because of degeneration of sensory 
receptors in the eye and inner ear (Bok D et. al., 2003). AE2 (SLC4A2) has been found to be 
expressed in fresh human, rabbit and bovine corneal endothelium (Sun XC et al, 2001) but there 
is still little evidence for its association with corneal diseases so far. 
The SLC4 family, except SLC4A11, can be functionally divided into three main groups 
(Fig. 1.3), namely anion exchangers (AEs), Na bicarbonate cotransporters (NBCs), sodium-
driven chloride/bicarbonate exchangers (NDCBE). We found that the expression of genes 
encoding the two NBCs (SLC4A4 and SLC4A7) to be next highly expressed after SLC4A11 




Table 4.1. Proposed hierarchy for SLC4 family members within a given functional group 
categorized thus according to their relative levels of expression in human corneal 
endothelium 
If one was to consider a group at a time, our data indicate that for NBCs, NBCe1 
(SLC4A4) is the primary member in the corneal endothelium and that NBCn1 (SLC4A7) is 
secondary. Similarly for AEs, AE2 (SLC4A2) appears to be primary to AE3 (SLC4A3). In the 
case of NDCBE family of proteins, AE1 (SLC4A1) is primary to NDCBE (SLC4A8). The 
redundancy seen with this family of genes is perhaps indicative of the important role that these 
genes play in ion transport within the corneal endothelium. It will also be interesting to explore 
the compensatory role played by the secondary gene in the event of a defect, i.e. mutation, 
involving the primary member of each class.   
Another notable factor about the SLC4 family is the expression of different splice 
variants and their tissue distribution. The pNBC1 (pancreatic variant) is expressed in cornea, 
conjunctiva, lens, ciliary body, and retina, whereas the expression of kNBC1 (kidney variant) is 
restricted to the conjunctiva in rat eye. (Bok D et. al., 2001) In human eye, the long isoform of 
the sodium bicarbonate cotransporter (pNBC-1) is expressed on the basolateral side of fresh 
human corneal endothelium (Sun XC et. al., 2003). In our study, we utilized primers that 
recognize the common ‘region’ amongst the splice variants for a given gene rather than focusing 
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on a particular splice variant. Therefore we are not able to draw conclusions about the 
expressions of a particular splice form. 
Our investigation established, on a small scale, expression profiles of all members of the 
SLC4 family in both MCECs and HCECs using real-time qPCR. Although there are limitations 
on the number of targeted genes that can be analyzed at a time, real-time qPCR can provide the 
simultaneous measurement of gene expression in many different samples (Schena M et. al., 1995, 
Fink L et. al., 1998, Higuchi R et. al., 2003). Nowadays, microarray analysis is becoming 
popular as a relatively rapid technique that allows parallel analysis of thousands of genes in a 
number of tissues (Lipshutz RJ et. al., 1999, Duggan DJ et. al., 1999). The expression of 
approximately 1200 genes have been identified using duplicate microarrays and a preliminary 
database of human corneal gene expression has been compiled (Jun AS et. al., 2001). However, 
the use of microarrays is limited by the finite number of oligonucleotide sequences localized on a 
chip and are not able to identify the expression of novel genes, unlike in the case of real time 
qPCR.  
 
4.1.2 Comparison of mouse and human gene expression pattern in corneal endothelium 
Often, rodents serve as a convenient model in many acid-base as well as genetic studies. 
Although studies on human gene expression of some acid-base transporters have been reported 
(Abuladze N et. al., 1998, Marino CR et. al., 1999, Amlal H et. al., 1999, Nishimura M et al 
2005, 2008),  few studies have compared the human expression pattern of these transporters with 
that of rodents. One study concluded that some selected human tissues display distinct 
expression patterns of HCO3
- 
transporters, which closely resemble that of rodent tissues 
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(Damkier HH et. al., 2007). Another study found, in mice, a similar pattern of corneal 
endothelial cell loss with aging and a comparable process of Descemet’s thickening over time 
(Joyce NC, 2003, Jun AS et al 2006). According to our study, in mouse corneal endothelium, the 
mRNA expression levels of SLC4 family in descending order of abundance is Slc4a11> Slc4a2> 
Slc4a4> Slc4a7> Slc4a3> Slc4a10> Slc4a5> Slc4a9> Slc4a8> Slc4a1 whilst in human corneal 
endothelium, the order is SLC4A11> SLC4A4> SLC4A2> SLC4A3> SLC4A7> SLC4A5> 
SLC4A1> SLC4A8> SLC4A10> SLC4A9, notably showing much similarity between mouse and 
human gene expression for this gene family. Interestingly, the complete resemblance is seen 
when they are divided into two main groups: high expression group with SLC4A11, SLC4A2, 
SLC4A4, SLC4A7, SLC4A3 and low expression group with SLC4A10, SLC4A5, SLC4A9, 
SLC4A8, SLC4A1. This suggests similar evolutionary forces at play in the regulation of 
expression of these genes in these two mammalian species as well as possible conservation of the 
functional role played by each member in solute transport in the corneal endothelium through 
evolution. 
 
4.1.3 Alteration in gene expression during corneal endothelial cell culture 
In our investigation, we observed that during MCEC culture, there was a transformation 
to a more fibroblastic-like phenotype in late passage 7 while in the case of HCECs, the cells 
could not grow well beyond passage 5. Furthermore, our qRT-PCR analyses also indicated 
marked changes in expression pattern of SLC4 transporter genes in both cultured MCECs and 
HCECs. One study stated that the cultured cells were not a good model for corneal endothelial 
transport studies since it was found thatAE2 was absent in cultured cells which is otherwise 
present in corneal endothelium . (Bonanno JA 2003) There were also two contradictory reports, 
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 cotransporter in cultured bovine corneal 
endothelial cells (Diecke F et. al., 1998)  while the other (Riley M et. al., 1997) being unable to 
show any cotransporter activity in the intact rabbit corneal preparations. Although culturing has 
some convenience and practical advantages over the native tissue, caution must be exercised 
when extending the results from the cultured cells to the native tissue. (Bonanno JA et. al., 1998) 
It can be postulated that the changed environmental conditions of culture media for the cells, for 
example high salt content, could be the key factor for altered expression seen for some genes, 
especially those of solute transporters, in  cultured cells. 
In this study, we found the SLC4A11 gene to be the most highly expressed member of the 
SLC4 gene family in the human cornea endothelium. Moreover, during cell culture SLC4A11 
gene expression was reduced by more than 70% in late passages. The morphology of endothelial 
cells was also less ‘endothelial like’ in late passages. A recent study showed that SLC4A11 gene 
was important for corneal endothelial cell survival and viability (Liu J et al, 2012). In this study, 
the authors used small hairpin RNAs (shRNAs) against SLC4A11 in a human corneal endothelial 
cell line (HCECs) to investigate the effects of SLC4A11 gene depletion. SLC4A11 knockdown 
was shown to suppress HCECs’ growth and reduce cell viability. This was associated with 
increased apoptosis in SLC4A11-silenced cells. The loss of ‘endothelial like’ state of cells and 
reduced expression of SLC4A11 gene seen in our current study also makes it tempting to 
speculate if the maintenance of endothelial cellular phenotype is one of the roles of SLC4A11 
gene as well as the maintenance of cell viability and survival. 
Another possible explanation for the observed gene expressional alterations is the so-
called Epithelial/endothelial-to-mesenchymal transition (E/EnMT) during which endothelial cells 
lose endothelial markers and obtain mesenchymal markers, as suggested by the elevated level of 
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Col1A1 in late passage cells. In vitro studies have shown that endothelial cells can undergo EMT, 
a process which is speculated to depend on transforming growth factor TGFß1 (Leask A et al, 
2004). Being the major cytokine in the anterior chamber of the eye (Melles GR 2006), high 
TGFß levels can lead to myofibroblast formation in the corneal endothelial layer (Reneker LW et. 
al., 2010). The drastically altered expression levels of the main genes SLC4A11 and SLC4A4, 
seen in late endothelial cell culture passages co-incident with altered cellular morphology 
indicate that further study should be undertaken to explore the possible link between SLC4 gene 
expression and EMT. 
 
4.2. Clinical relevance of the study 
Several SLC4 bicarbonate transporter genes have been linked to a wide range of diseases 
(Table 1.3) including some eye disorders. The SLC4 gene family members expressed in the 
cornea, which are not yet identified as being involved in any corneal diseases, are potential 
candidate genes to be interrogated in corneal endothelial diseases. Identification and 
characterization of more genes causative of corneal endothelial diseases would further our 
understanding of pathologic mechanisms underlying this group of disorders and may lead to 
novel ways to treat these conditions. In this study the expression profiles of SLC4 family 
members were characterised in both the mouse and human corneal endothelium. Understanding 
the hierarchy of expression of bicarbonate transporters within the same functional group has also 
opened up the interesting possibility of compensatory therapeutics. For instance, if mutations in 
SLC4A4 lead to functional loss of the protein (NBCe1), one can explore whether up regulating 
the expression of its related secondary member of same functional group, NBCn1, encoded by 
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SLC4A7, can have possible therapeutic benefit.  This would of course require the identification 
of pharmaceutical drugs that can specifically up regulate these SLC4 transporter genes/proteins. 
Some solute carriers are also responsible for drug transport in various tissues and they 
may be key determinants of the pharmacokinetic characteristics of drugs (Mizuno N et. al., 2003, 
2002, Katsura T et. al., 2003). Similarly, SLC4A bicarbonate transporters may become promising 
candidates for drug delivery (Nishimura M et. al., 2008). 
Corneal blindness, a second leading cause of visual blindness (Whitcher JP et al, 2001), 
is caused by corneal endothelial dysfunction (Carlson KH et al, 1988) and restoration of vision is 
possible only by corneal transplantation (Engelmann K et al, 2004). However, shortage of 
transplant-grade donor corneas is a current pressing matter worldwide (McColgan K, 2009) and 
hence the development of tissue-engineered constructs is an urgent requirement. Understanding 
the gene expression profile of the corneal endothelium, with regard to important genes like 
SLC4A11, will lead to the development of high quality tissue-engineered constructs with more 
expressional resemblance to native tissue. Such constructs will eventually be able to replace 
donor corneas in transplantation.    
    
4.3. Technical difficulties and limitations of current study 
The use of mice in corneal research is technically challenging due to the small size of the 
murine eye globe and the fragility of the cornea. Stripping of Descemet’s membrane from a 
cornea, especially from the mouse cornea, under a dissecting microscope was a very time-
consuming and tedious work. Extreme care also had to be taken not to contaminate with the 
stromal layers and fibroblast cells.  
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The high cost of human corneal samples also posed no room for errors throughout the 
entire experiment, from Descement’s membrane stripping to real time qPCR. Much practice had 
to be exercised using cadaveric corneal rims before performing actual tests with ordered corneas.  
Due to the small size of the specimen, which is merely a single layer of endothelial cells, RNA 
yield was very low as expected; therefore a number of corneal endothelia from the same litter of 
mice had to be pooled to obtain sufficient quantities of RNA. The quality of primers also plays a 
significant role in the performance of qRT-PCR. The primer pair for each gene was therefore 
carefully designed to be sensitive and specific for the gene of interest. If any non-specificity was 
observed in empirical experiments, primers were redesigned until optimal results were obtained.  
The main limiting factor in this study is that gene expression levels were only tested at 
the RNA level and not at the protein level. Ideally, the expression levels should have been 
confirmed by using specific antibodies to the various SLC4 genes in western analysis. The small 
number of human corneal samples (n=5) was another limitation in this study. Thirdly, the use of 
a few housekeeping genes for normalization is also not ideal although we applied three stable 
housekeeping genes out of four, instead of traditional use of a single gene. Only four HKGs were 
chosen due to the small yield of RNA and cDNA. With the gradual realization that the 
expression of traditionally used HKGs like ACTB and GAPDH are not stable in all tissues/cells 
or under all conditions (Thellin O et. al., 1999, Barber RD et. al., 2005, Selvey S et. al., 2001, 
Suzuki T et. al., 2000, Glare EM et. al., 2002), the use of a combination of multiple stable HKGs 
for proper normalization is advocated. A panel of at least eight or ten HKGs should therefore be 






4.4. Possible future work/experiments  
 Further studies, involving larger number of both human samples and HKGs, can be 
carried out to validate this pilot project.  
 The protein expression and distribution of SLC4 family members in human corneal 
endothelium can be confirmed by Western and immunohistochemical analyses. 
 The expression pattern of all splice variants for each SLC4 transporter in CECs can be 
studied to gain more knowledge on different splice variants.   
 Mutational screening of this study’s candidate genes can be performed on a panel of 
FECD patients’ DNA samples. 
 Specific endothelial cell markers and mesenchymal cell markers can be applied on 

















To the best of our knowledge, this is the first ever study to investigate the expression 
levels of the entire SLC4 bicarbonate transporter family in corneal endothelial cells of both 
human and mouse.  We could establish expression profiles for each member in primary corneal 
endothelium of human and mouse. We could also quantify the expressional alterations that occur 
for SLC4 genes due to cell culturing procedure involving both early and late subcultures. 
Interestingly, the two members, SLC4A11 and SLC4A4, already known for their involvement in 
corneal endothelial dystrophies, were found to be the most highly expressed in corneal 
endothelium. Thus we speculate that the other two highly expressed genes, SLC4A2 and SLC4A7 
are worthy of being considered next as potential candidate genes for corneal endothelial diseases. 
The drastically altered expression levels of the main genes SLC4A11 and SLC4A4, seen in late 
endothelial cell culture passages co-incident with altered cellular morphology indicate that 




Part of this study “Investigation of the relative expression levels of SLC4 bicarbonate 
transporter family members in mouse corneal endothelial cells (MCECs)” was selected for poster 
presentation at the Inaugural SingHealth Duke-NUS Scientific Congress, held at Concourse, 
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